Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

Background Relationships and sex education (RSE) impacts some sexual behaviours but could be strengthened by incorporating ...

Operator: Greetings, and welcome to the Five Point Holdings, LLC Third Quarter 2025 Conference Call. As a reminder, this call is being recorded.

Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...

Net Loss -- Net loss was $13.6 million for the third quarter of 2025, compared to $16.4 million in Q3 2024. Ending Cash, Cash Equivalents, and Investments -- $168.5 million in cash, cash equivalents, ...

Representing 58.4% of Total RevenueStrong Q3 Profitability: 9.0% Net Income margin and 32.8% Adjusted EBITDA marginUpdates 2025 Revenue and Adjusted EBITDA GuidanceFinalizes Strategic Partnerships to ...

Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Hello, and thank you for standing by. Welcome to Allogene ...

fuboTV Inc. (NYSE: FUBO) Q3 2025 Earnings Call Transcript November 3, 2025 fuboTV Inc. misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $-0.04.

Fiscal 2026 Guidance Raised -- Revenue outlook increased to $605 million-$620 million for fiscal 2026 (from $590 million-$610 million), and adjusted EBITDA (non-GAAP) to $78 million-$81 million for ...

The company is seeing rapid growth in its operations, expanded customer activity, and as a stable financial position heading ...

Many people consider the Union Public Service Commission (UPSC) examination to be one of the most difficult exams in India. Millions of people apply for the exam each year, but only a select handful ...